A senior pharmaceutical executive from Mumbai, controlling a portfolio of healthcare ventures valued at over $120 million, approached Broadment to restructure international corporate holdings in support of residency eligibility and tax optimization. The principal required a multi-jurisdictional corporate framework that would satisfy economic substance requirements for immigration programs while minimizing global tax exposure and maintaining operational flexibility across Asian and European markets.